Effects of angiotensin converting enzyme inhibitor and angiotensin II receptor antagonist therapy in hypertensive renal transplant recipients

Transplant Proc. 2002 Dec;34(8):3223-4. doi: 10.1016/s0041-1345(02)03688-6.

Authors

W Kim¹, S Lee, S K Kang, H C Yu, B H Cho, S K Park

Affiliation

¹ Department of Internal Medicine, Chonbuk National University Medical School, Jeonju, South Korea.

PMID: 12493427
DOI: 10.1016/s0041-1345(02)03688-6

No abstract available

Publication types

Clinical Trial
Controlled Clinical Trial

MeSH terms

Adult
Angiotensin Receptor Antagonists*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Antihypertensive Agents / therapeutic use*
Blood Pressure
Creatinine / blood
Drug Therapy, Combination
Enalapril / therapeutic use
Female
Humans
Hypertension / drug therapy*
Immunosuppressive Agents / therapeutic use
Kidney Transplantation / immunology
Kidney Transplantation / physiology*
Losartan / therapeutic use
Male
Postoperative Complications / drug therapy
Potassium / blood
Proteinuria
Receptor, Angiotensin, Type 1
Uric Acid / blood

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Immunosuppressive Agents
Receptor, Angiotensin, Type 1
Uric Acid
Enalapril
Creatinine
Losartan
Potassium